APA

Azin H., Vazirinejad R., Ahmadabadi B. N., Khorramdelazad H., Zarandi E. R., Arababadi M. K., Karimabad M. N., Shamsizadeh A., Rafatpanah H. & Hassanshahi G. (20130411). The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. : Journal of molecular neuroscience : MN.

Chicago

Azin Hossein, Vazirinejad Reza, Ahmadabadi Behzad Nasiri, Khorramdelazad Hossein, Zarandi Ebrahim Rezazadeh, Arababadi Mohammad Kazemi, Karimabad Mojgan Noroozi, Shamsizadeh Ali, Rafatpanah Houshang and Hassanshahi Gholamhossein. 20130411. The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. : Journal of molecular neuroscience : MN.

Harvard

Azin H., Vazirinejad R., Ahmadabadi B. N., Khorramdelazad H., Zarandi E. R., Arababadi M. K., Karimabad M. N., Shamsizadeh A., Rafatpanah H. and Hassanshahi G. (20130411). The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. : Journal of molecular neuroscience : MN.

MLA

Azin Hossein, Vazirinejad Reza, Ahmadabadi Behzad Nasiri, Khorramdelazad Hossein, Zarandi Ebrahim Rezazadeh, Arababadi Mohammad Kazemi, Karimabad Mojgan Noroozi, Shamsizadeh Ali, Rafatpanah Houshang and Hassanshahi Gholamhossein. The SDF-1 3'a genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. : Journal of molecular neuroscience : MN. 20130411.